Over the past 12 months, Legend Biotech insiders sold $566,755 of stock on the open market (54.3K shares) and made no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ingrid Zhang | Chief Executive Officer | 1,131,860 | 0 | 1,131,860 | 62.6% | 16 Sep, 2026 |
| 2 | Ying Huang | Chief Executive Officer | 238,490 | 0 | 238,490 | 13.2% | 02 Jul, 2026 |
| 3 | Darren Xiaohui Ji | Director | 92,103 | 0 | 92,103 | 5.1% | 28 Sep, 2026 |
| 4 | Patrick John Casey | Director | 69,590 | 0 | 69,590 | 3.8% | 28 Sep, 2026 |
| 5 | Li Mao | Director | 65,316 | 0 | 65,316 | 3.6% | 28 Sep, 2026 |
| 6 | Peter Salovey | Director | 55,096 | 0 | 55,096 | 3.0% | 28 Sep, 2026 |
| 7 | Tomas J. Heyman | Director | 53,720 | 0 | 53,720 | 3.0% | 28 Sep, 2026 |
| 8 | Corazon (Corsee) D. Sanders | Director | 52,731 | 0 | 52,731 | 2.9% | 01 Oct, 2026 |
| 9 | Alan Bash | Interim Ceo | 35,142 | 0 | 35,142 | 1.9% | 18 Aug, 2026 |
| 10 | Carlos E Santos | Chief Financial Officer | 14,246 | 0 | 14,246 | 0.8% | 23 Sep, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 29 Sep, 2026 | Corazon (Corsee) D. Sanders | Director | Disposed S | 27,370 | $9.46 | $258.92K | 52,731 | Direct |
| 24 Sep, 2026 | Corazon (Corsee) D. Sanders | Director | Acquired A | 20,986 | $0.00 | $0 | 80,101 | Direct |
| 24 Sep, 2026 | Tomas J. Heyman | Director | Acquired A | 20,986 | $0.00 | $0 | 53,720 | Direct |
| 24 Sep, 2026 | Darren Xiaohui Ji | Director | Acquired A | 28,330 | $0.00 | $0 | 92,103 | Direct |
| 24 Sep, 2026 | Patrick John Casey | Director | Acquired A | 20,986 | $0.00 | $0 | 69,590 | Direct |
| 24 Sep, 2026 | Peter Salovey | Director | Acquired A | 28,330 | $0.00 | $0 | 55,096 | Direct |
| 24 Sep, 2026 | Li Mao | Director | Acquired A | 20,986 | $0.00 | $0 | 65,316 | Direct |
| 21 Sep, 2026 | Carlos E Santos | Chief Financial Officer | Acquired A | 19,676 | $0.00 | $0 | 19,676 | Direct |
| 21 Sep, 2026 | Carlos E Santos | Chief Financial Officer | Disposed S | 5,430 | $9.14 | $49.63K | 14,246 | Direct |
| 15 Sep, 2026 | Ingrid Zhang | Chief Executive Officer | Acquired A | 1,131,860 | $0.00 | $0 | 1,131,860 | Direct |
| 14 Aug, 2026 | Alan Bash | Interim Ceo | Acquired A | 4,908 | $0.00 | $0 | 35,142 | Direct |
| 30 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed G | 3,382 | $0.00 | $0 | 238,490 | Direct |
| 30 Jun, 2026 | Patrick John Casey | Director | Disposed S | 6,000 | $14.80 | $88.80K | 48,604 | Direct |
| 25 Jun, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 5,566 | $14.78 | $82.27K | 241,872 | Direct |
| 25 Mar, 2026 | Ying Huang | Chief Executive Officer | Disposed S | 9,936 | $8.77 | $87.14K | 247,438 | Direct |